Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study
| Autor: | GH Huang, S Luo, Cai Zhang, J He, JP Huang |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
medicine.medical_specialty Endometrioses medicine.medical_treatment Population Operative Time Endometriosis Abdominal wall 03 medical and health sciences 0302 clinical medicine Postoperative Complications Obstetrics and gynaecology Muscular Diseases medicine Humans education Retrospective Studies education.field_of_study 030219 obstetrics & reproductive medicine business.industry Ultrasound Abdominal Wall Obstetrics and Gynecology medicine.disease Ablation High-intensity focused ultrasound Surgery medicine.anatomical_structure Treatment Outcome 030220 oncology & carcinogenesis High-Intensity Focused Ultrasound Ablation Female Radiology business |
| Zdroj: | BJOG : an international journal of obstetrics and gynaecology. 124 |
| ISSN: | 1471-0528 |
| Popis: | Objective To evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for treating abdominal wall endometrioses (AWE). Design A retrospective study. Setting Department of Obstetrics and Gynaecology in China. Population Patients with abdominal wall endometriosis. Methods From August 2010 to April 2014, 32 patients with AWE were treated with USgHIFU in our hospital. USgHIFU treatment was performed with the Model JC-200 High Intensity Focused Ultrasound Tumor Therapeutic System. The symptom relief and the adverse effects were evaluated after USgHIFU ablation. Main outcome measures USgHIFU as a new treatment option for patients with AWE. Results Contrast-enhanced ultrasound showed that all lesions were successfully ablated with USgHIFU. The follow-up results showed that the average volume of AWE lesions at 6 months after USgHIFU was significantly smaller than that before treatment (2.80 ± 0.12 versus 1.33 ± 0.31 cm3). The pain scores at 6 months after treatment were significantly lower than those before treatment (6.80 ± 2.64 versus 1.80 ± 0.3). The non-perfused volume (indicative of successful ablation) was measured in all patients immediately after treatment, ranging from 0.9 to 2.1 cm3 (median: 1.6 cm3), and the fractional ablation ranged from 87% to 100% (median: 94%). Local oedema was observed in these patients, lasting for 1–3 days only. No severe complications occurred during the follow-up period. Conclusions Based on our study, USgHIFU ablation is a safe and effective method for treating AWE. Tweetable abstract As a non-invasive treatment technique, HIFU could be used to treat abdominal wall endometriosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text